Skip to content
Disclosery

EXANE DERIVATIVES: DBX position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on DBX, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 135 DBX shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 135 shares
    Change vs previous 13F 0 shares

    <0.01% of the 13F portfolio, value $2,833.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 135 shares
    Change vs previous 13F -1 shares

    <0.01% of the 13F portfolio, value $3,139.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 136 shares
    Change vs previous 13F -12,507 shares

    <0.01% of the 13F portfolio, value $3,338.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 12,643 shares
    Change vs previous 13F +12,302 shares

    0.09% of the 13F portfolio, value $369,436.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 341 shares
    Change vs previous 13F -10,764 shares

    <0.01% of the 13F portfolio, value $10,523.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 11,105 shares
    Change vs previous 13F -705 shares

    0.09% of the 13F portfolio, value $296,067.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 11,810 shares
    Change vs previous 13F -3,272 shares

    0.08% of the 13F portfolio, value $262,070.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 15,082 shares
    Change vs previous 13F not available

    0.09% of the 13F portfolio, value $290,481.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).